SWOT Analysis for Arcus Biosciences Inc

Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Company with Low Debt
Top Gainers
Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding
Promoter holding decreased by more than -2% QoQ
New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
RSI indicating price weakness
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter